P
PharmaCyte Biotech, Inc. (PMCB)
NCM – Real Time Price. Currency in USD
0.79
+0.10 (13.69%)
At close: May 12, 2026, 4:00 PM EDT
0.79
0.00 (0.00%)
After-hours: May 12, 2026, 7:55 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.79
+0.10 (13.69%)
At close: May 12, 2026, 4:00 PM EDT
0.79
0.00 (0.00%)
After-hours: May 12, 2026, 7:55 PM EDT
No Data
There are no news for this stock.
Cash reserves $20.2M barely cover the upcoming debt maturities $0.0
Total current assets $20.7M exceed Total current liabilities $1.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$786.9K limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 12.33 | 6.05 | 10 | |
| Quick ratio | 12.33 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -4M | -6M | -7M | -4M | -5M |
| Net Income | -4M | -4M | 334K | 31M | -3M |
| EBITDA | -4M | -6M | -7M | -4M | -5M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 110.07 | N/A | 19.67 | 7.5 |
| Y/Y | 999 | 124.52 | N/A | -54.31 | 5.5 |
| 3y average | 999 | 3063.64 | N/A | 4.24 | 6.3 |
| 5y average | 999 | 1835.75 | N/A | -10.65 | 5.5 |
| Weighted average score | 6.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |